The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase I study of mesothelin-targeted immunotoxin LMB-100 in combination with tofacitinib in patients with advanced pancreatobiliary cancer.
 
Nebojsa Skorupan
No Relationships to Disclose
 
Mehwish Iqra Ahmad
No Relationships to Disclose
 
Guillaume Joe Pegna
No Relationships to Disclose
 
Cody J. Peer
No Relationships to Disclose
 
Jane B. Trepel
Research Funding - AstraZeneca (Inst); EpicentRX (Inst); Syndax (Inst)
 
Min-Jung Lee
No Relationships to Disclose
 
Sunmin Lee
No Relationships to Disclose
 
Shraddha Rastogi
No Relationships to Disclose
 
Nahoko Sato
No Relationships to Disclose
 
William Douglas Figg
Research Funding - Astellas Pharma (Inst); Biocompatibles (Inst); Celgene (Inst); Nerviano Medical Sciences (Inst); NovaRX (Inst); Pfizer (Inst); TRACON Pharma (Inst)
 
Raffit Hassan
No Relationships to Disclose
 
David JP FitzGerald
Stock and Other Ownership Interests - Applied Molecular Transport
Patents, Royalties, Other Intellectual Property - Assigned to US Gov
 
Ira Pastan
Patents, Royalties, Other Intellectual Property - I have patents, all assigned to the NIH (Inst)
 
Christine Alewine
No Relationships to Disclose